Astec LifeSciences Limited reported earnings results for the fourth quarter ended March 31, 2023. For the fourth quarter, the company reported sales was INR 1,269.72 million compared to INR 2,719.82 million a year ago. Revenue was INR 1,295.47 million compared to INR 2,787.87 million a year ago.

Net loss was INR 49.83 million compared to net income of INR 430.55 million a year ago. Basic loss per share from continuing operations was INR 2.54 compared to basic earnings per share from continuing operations of INR 21.97 a year ago. Diluted loss per share from continuing operations was INR 2.54 compared to diluted earnings per share from continuing operations of INR 21.96 a year ago.